Page 103 - Cap Ltd News Today

Eve Sleep plc: Result of AGM DJ Eve Sleep plc: Result of AGM Eve Sleep plc (EVE) Eve Sleep plc: Result of AGM 26-May-2021 / 14:55 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. =---------------------------------------------------------------------------------------------------------------------- eve Sleep plc ("eve" or the "Company") Result of AGM eve Sleep, the direct to consumer sleep...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

  Proactis Holdings PLC, ("Proactis", the "Group" or the "Company"), the business spend management solution provider, today reports that it is currently managing a cyber security incident after detecting unauthorised access to a limited number of its internal systems. None of the customer systems provided by the Group have been affected by the incident.   The Company has notified the relevant regulators and law enforcement agency, including the Information Commissione...

Provided by Accesswire Parsortix system consistently harvests CTCs of high quality Research paves the way for downstream molecular analysis to enable targeted treatment in this hard-to-treat cancer GUILDFORD, UK / ACCESSWIRE / May 20, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce that the University Hospital Ghent, Belgium has published results of research undertaken in oesophageal cancer, using ANGLEs Parsortix® syste...

    Brighton, United Kingdom - 19 May 2021 - Destiny Pharma plc (AIM: DEST) a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, as announced on 4 May 2021, will hold its 2021 Annual General Meeting ("AGM") at the offices of finnCap Ltd, Destiny Pharmas Nominated Advisor and Joint Broker, at 11.00am BST on 3 June 2021. Destiny Pharma will operate an audio dial-in facility to allow Shareholders to li...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

ANGLE plc: Angle PLC Announces Exercise of options and total voting rights GUILDFORD, SURREY / ACCESSWIRE / May 19, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that following the exercise of employee options, it has issued and allotted 216,000 new Ordinary shares of £0.10 each ("New Ordinary Shares") in the Company. The New Ordinary Shares rank pari passu with the existing Ordinary shares in the Company. An application has been made to the London S...

About ANGLE plc www.angleplc.com ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLEs proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.   ANGLEs cell separation technology is called the Parsortix ®   system, and it enables a liquid biopsy (a simp...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...